A Study To Assess The Safety Of PF-06342674 In Healthy Volunteers

NCT01740609 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Placebo
BIOLOGICAL: PF-06342674 Dose A
BIOLOGICAL: PF-06342674 Dose B
BIOLOGICAL: PF-06342674 Dose C
BIOLOGICAL: PF-06342674 Dose D
BIOLOGICAL: PF-06342674 Dose E
BIOLOGICAL: PF-06342674 Dose F
BIOLOGICAL: PF-06342674 Dose G
BIOLOGICAL: PF-06342674 Dose H
BIOLOGICAL: PF-06342674 Dose I
BIOLOGICAL: PF-06342674 Dose J

Sponsor

Pfizer